Full-Time

Microbiology Supervisor

Quality Control

Posted on 9/3/2026

Kincell Bio

Kincell Bio

51-200 employees

Cell therapy CDMO: development, CMC, manufacturing

No salary listed

Durham, NC, USA

In Person

Bachelor's, Master's

Category
Biology & Biotech (1)
Required Skills
Microbiology
Data Analysis

Get referred to Kincell Bio

See people who can refer or advise you

Requirements
  • A bachelor's degree in Microbiology, Biology, or another relevant scientific discipline and a minimum of 4 years of relevant microbiology laboratory experience in a GMP-regulated environment.
  • Demonstrated experience performing and/or overseeing microbiological testing and environmental monitoring in a GMP-regulated environment.
  • Hands-on experience with aseptic gowning and working within classified cleanroom environments.
  • Demonstrated proficiency in microbiological testing, including sterility, bacterial endotoxin, growth promotion, bioburden, microbial enumeration, subculture techniques, environmental monitoring, compressed gas testing, microbial identification, and Gram staining.
  • Experience with microbiology investigations, including environmental monitoring excursions, atypical results, out-of-specification events, root cause analysis, and impact assessments.
  • Experience developing, executing, reviewing, and documenting microbiology protocols, investigations, reports, and technical assessments.
  • Experience with microbiological method verification, method suitability, and/or validation activities.
  • Demonstrated ability to provide technical leadership, training, mentoring, and oversight of microbiology personnel.
  • Working knowledge of GMP requirements, aseptic practices, contamination control principles, data integrity, and applicable microbiology standards and compendial requirements.
  • Ability to prioritize and manage multiple complex activities simultaneously using strong organizational, analytical, and problem-solving skills.
  • Ability to evaluate microbiological data, identify trends and potential adverse patterns, establish scientifically sound conclusions, and make risk-based decisions.
  • Ability to effectively communicate technical information across functional groups through written and verbal communication.
  • Ability to work independently, exercise sound judgment, and provide effective technical direction in a fast-paced GMP environment.
  • Ability to work off-hours, weekends, or extended hours when required to support manufacturing and laboratory operations.
  • Ability to wear required cleanroom and personal protective equipment, including full-body gowning, goggles, face shields, protective gloves, and other applicable personal protective equipment.
Responsibilities
  • Provide day-to-day leadership, technical direction, and oversight of quality-control microbiology and environmental-monitoring activities supporting good manufacturing practice manufacturing operations.
  • Coordinate and prioritize microbiology workload to ensure timely completion of environmental monitoring, quality-control testing, investigations, and other laboratory activities.
  • Serve as a hands-on technical resource and primary backup for microbiological testing activities while maintaining proficiency in applicable microbiological methods.
  • Perform microbiological testing as needed to support laboratory workload, manufacturing schedules, investigations, staffing requirements, and off-hours or weekend coverage.
  • Oversee environmental monitoring activities, including viable air, surface, personnel, compressed gas, and other applicable monitoring within classified cleanrooms and laboratory areas.
  • Coordinate microbiological testing performed by external contract laboratories, including sample submission, test requirements, result review, and reconciliation of final reports.
  • Oversee and perform microbiological media preparation, growth promotion testing, and media qualification in accordance with approved procedures and applicable compendial requirements.
  • Provide technical oversight and hands-on support for sterility testing, method verification, and method suitability activities, including testing performed using the BacT/ALERT 3D System.
  • Ensure microbiology laboratory equipment is appropriately maintained, calibrated, qualified, and available for intended use.
  • Lead and/or support microbiology investigations, including environmental monitoring excursions, atypical results, out-of-specification events, and other microbiological events.
  • Support root cause analysis, product and facility impact assessments, corrective and preventive actions, and effectiveness evaluations associated with microbiological events.
  • Develop, review, and execute microbiology protocols, investigations, reports, technical assessments, and other controlled documentation.
  • Support qualification and validation activities for microbiology equipment, processes, facilities, and analytical methods, including protocol development, execution, data review, and report generation.
  • Review microbiology records, analytical data, protocols, reports, and other controlled documentation for accuracy, completeness, compliance, and data integrity.
  • Analyze and trend microbiological and environmental monitoring data to identify potential adverse trends, recurring events, or opportunities for improvement.
  • Train, mentor, and qualify microbiology personnel and provide ongoing technical coaching to ensure personnel maintain required competencies.
  • Coordinate daily laboratory activities and provide technical guidance to microbiology personnel to ensure appropriate execution of testing and adherence to established procedures.
  • Maintain the microbiology laboratory in a clean, orderly, compliant, and inspection-ready state.
  • Collaborate with Quality Assurance, Manufacturing, Engineering, Validation, and other cross-functional groups to support manufacturing operations, investigations, contamination control, qualification activities, and continuous improvement initiatives.
  • Participate in internal audits, regulatory inspections, and other quality assessments as a microbiology subject matter expert, as applicable.
  • Identify and implement opportunities to improve microbiology laboratory processes, testing efficiency, environmental monitoring practices, contamination control, and overall laboratory performance.
  • Ensure compliance with company policies, procedures, standard operating procedures, good manufacturing practice requirements, applicable regulatory expectations, and data integrity principles.
Desired Qualifications
  • A master's degree in Microbiology, Biology, or a related scientific discipline.
  • 5+ years of experience in a GMP-regulated pharmaceutical, biotechnology, cell therapy, or other similarly regulated environment.
  • Previous experience in a lead, senior technician, supervisory, or technical leadership role.
  • Experience supporting cell therapy or aseptic manufacturing operations.
  • Experience with contamination control strategy development and implementation.
  • Experience with environmental monitoring program development, qualification, trending, and data analysis.

Kincell Bio provides manufacturing and development services for companies creating immune cell therapies, such as CAR-T and CAR-NK treatments. The company works by acting as an extension of its clients' teams, handling the complex process of turning laboratory research into clinical-grade products through specialized consulting and factory production. Unlike larger competitors, Kincell focuses specifically on the needs of early-stage biotech startups and academic spinouts by offering personalized partnerships and scalable facilities. Its goal is to streamline the path from initial research to clinical trials by solving the manufacturing challenges that often slow down new medical treatments.

Company Size

51-200

Company Stage

Early VC

Total Funding

$58M

Headquarters

Gainesville, Florida

Founded

2023

Get referred to Kincell Bio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The 2026-04-14 RTP investment directly meets rising late-stage and commercial supply demand.
  • NewSpring's 2025-05-15 $22 million round extends runway for equipment, quality, and systems.
  • Kincell's Gainesville and RTP split supports early development, pivotal supply, and launch manufacturing.

What critics are saying

  • RTP expansion must finish by Q3 2026; any delay misses commercialization timelines.
  • Lonza, Catalent, and Forge Biologics outspend Kincell on capacity, quality systems, and client acquisition.
  • A single clinical-program concentration or client loss can cripple revenue before commercial scale arrives.

What makes Kincell Bio unique

  • Larry Pitcher became CEO on 2026-01-06 after scaling Catalent's Maryland gene therapy site.
  • Kincell's RTP expansion added two ISO 7 suites, targeting late-stage and commercial cell therapies.
  • The RegCell partnership on 2026-02-10 embeds Kincell in autoimmune Treg clinical manufacturing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Relocation Assistance

Employee Referral Bonus

Student Loan Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Professional Development Budget

Conference Attendance Budget

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Wellness Program

Mental Health Support

Gym Membership

Commuter Benefits

Meal Benefits

Phone/Internet Stipend

Home Office Stipend

Legal Services

Employee Discounts

Company Social Events

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

2%

2 year growth

0%
European Pharmaceutical Review
Jan 19th, 2026
Kincell Bio promotes Bruce Thompson to President and Chief Technology Officer

Kincell Bio promotes Bruce Thompson to President and Chief Technology Officer. The cell therapy-focused CDMO has also elevated Melodie Bryce to Chief Quality Officer and Matt Haines to Chief Operations Officer. Cell therapy-focused contract development and manufacturing organisation (CDMO) Kincell Bio has made a trio of promotions to its senior leadership team. * Mandatory essentials of USP General Chapter 41 -calibration, minimum weight, repeatability and accuracy requirements, and performance checks * Informational statements of USP General Chapter 1251 - the concept of a safety factor * Performance checks - general requirements Its speaker will address specific USP-related questions in a Q&A format at the end of the webinar. The US firm has promoted its founding CEO Bruce Thompson to President and Chief Technology Officer and elevated Melodie Bryce to Chief Quality Officer and Matt Haines to Chief Operations Officer. Kincell Bio's Chief Executive Officer Larry Pitcher said: "Bruce, Melodie and Matt have demonstrated exceptional leadership and expertise, and their expanded roles further strengthen its ability to deliver innovative, high-quality solutions for its clients while accelerating access to transformative therapies for patients. "Together with our highly skilled teams, we will continue to expand our clinical development and commercial supply infrastructure, accelerate technology transfer and strengthen our commitment to delivering life-changing cell therapies efficiently and reliably." Thompson's prior leadership roles include VP of Process Sciences at Lyell Immunopharma. He has also held technical and operational leadership positions at Resilience and Fred Hutchinson Cancer Research Center, where he led GMP manufacturing of cell and gene therapy products. Bryce has nearly three decades of experience in quality leadership, spanning cell therapy, antibody and aseptic production, previously held senior quality leadership roles at KBI Biopharma, Cognate BioServices, Matica Biotechnology and Fujifilm Diosynth Biotechnologies. Meanwhile, Haines brings to his new role over 20 years of biotech experience, specialising in manufacturing sciences and operations at Biogen, Amgen and Merck. Before joining Kincell, he served as VP of Manufacturing Operations at Inceptor Bio, a cell therapy innovator, and Senior Director at AveXis/Novartis Gene Therapies.

Contract Pharma
Jan 6th, 2026
Kincell Bio Promotes Lawrence Pitcher to CEO

Kincell Bio promotes Lawrence Pitcher to CEO. Pitcher offers experience scaling cell and gene therapy manufacturing operations and aligning them with client and patient needs. Kincell Bio, a contract development and manufacturing organization (CDMO) in cell therapy, has promoted Lawrence "Larry" Pitcher to Chief Executive Officer, effective immediately. Pitcher succeeds Mark R. Bamforth OBE, who guided the company through a successful phase of growth as CEO and will continue to support the transition in a strategic capacity as Executive Chair of the Board. "Larry has a proven track record scaling cell and gene therapy manufacturing operations and aligning them with client and patient needs," said Mark R. Bamforth OBE. "His leadership of our operational capabilities positions Kincell Bio to better serve our clients as they progress into late-stage trials and commercial launch." As COO since March 2025, Pitcher has been instrumental in applying his experience to expanding Kincell Bio's production capabilities, processes, and systems to support pivotal and commercial-stage cell therapies. Prior to joining Kincell Bio, he served as VP & GM at Catalent's Maryland gene therapy site where he cultivated robust commercial manufacturing operations and drove significant revenue and profitability gains. His earlier roles include leadership positions at Thermo Fisher, Brammer Bio, and RTI Surgical across Europe and the U.S., where he delivered consistent operational excellence and growth. With a B.S. in Industrial Engineering from Western Michigan University and an MBA from the University of Florida, Pitcher brings technical expertise and strategic vision to the CEO role. He takes the helm at a pivotal time as Kincell Bio accelerates cell therapy product supply from its Research Triangle Park, NC, and Gainesville, FL sites. "I'm honored to assume the CEO role at Kincell Bio. Together with our skillful teams, we will expand our clinical development and commercial supply infrastructure, accelerate technology transfer, and strengthen our commitment to deliver life-changing cell therapies efficiently and reliably," Pitcher shared.

Business Wire
May 16th, 2025
NewSpring Capital and Kineticos Life Sciences Lead $22 Million Investment in Cell Therapy CDMO, Kincell Bio; Appoints Industry Veteran Pete Buzy to Board of Directors

Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring Capital through its dedicated healthcare strategy, NewSpring He...

FinSMEs
May 15th, 2025
Kincell Bio Raises $22M in Funding

Kincell Bio raises $22M in funding.

Morningstar
May 15th, 2025
Kincell Bio secures $22M investment boost

NewSpring Capital and Kineticos Life Sciences led a $22 million investment in Kincell Bio, a cell therapy CDMO. Industry veteran Pete Buzy was appointed to Kincell Bio's Board of Directors. The funding will enhance Kincell Bio's cGMP capabilities and process development services. This positions Kincell Bio as a leader in biomanufacturing, with the cell and gene therapy market projected to surpass $23 billion globally by 2028.